Vanguard Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Vanguard Capital Management's AMRX Position: Q3 2026 in Review
Vanguard Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 3.6% in Q3 2026, buying an estimated $5M and bringing the position to 7,987,664 shares worth $161M. The position accounts for ﹤0.01% of the portfolio, ranked #1246.
Vanguard Capital Management first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Vanguard Capital Management held 7,987,664 shares of Amneal Pharmaceuticals worth $161M as of Q3 2026.
- Vanguard Capital Management bought 277,538 Amneal Pharmaceuticals shares in Q3 2026, an estimated $5M.
- Amneal Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1246 holding.
- Vanguard Capital Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.